David, J. A., Rifkin, W. J., Rabbani, P. S., & Ceradini, D. J. (2017). The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus. J Diabetes Res.
Citação norma ChicagoDavid, Joshua A., William J. Rifkin, Piul S. Rabbani, and Daniel J. Ceradini. "The Nrf2/Keap1/ARE Pathway and Oxidative Stress As a Therapeutic Target in Type II Diabetes Mellitus." J Diabetes Res 2017.
MLA citiranjeDavid, Joshua A., William J. Rifkin, Piul S. Rabbani, and Daniel J. Ceradini. "The Nrf2/Keap1/ARE Pathway and Oxidative Stress As a Therapeutic Target in Type II Diabetes Mellitus." J Diabetes Res 2017.
Opozorilo: Ti citati niso vedno 100% točni.